Increased preferential absorption in human atherosclerotic plaque with oral beta carotene. Implications for laser endarterectomy.
Author(s) -
Martin R. Prince,
Glenn M. LaMuraglia,
Edward F. MacNichol
Publication year - 1988
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/01.cir.78.2.338
Subject(s) - medicine , beta carotene , in vivo , beta (programming language) , absorption (acoustics) , carotid endarterectomy , pathology , cardiology , stenosis , biology , materials science , microbiology and biotechnology , vitamin , computer science , composite material , programming language
Patients undergoing carotid endarterectomy were pretreated with low-dose, oral beta carotene to determine whether the carotenoid content of plaque could be increased in vivo. Beta carotene-treated patients had a 50-fold increase in their plaque beta carotene level from 0.066 to 3.3 micrograms beta carotene/g plaque. Microscopy and microspectrophotometry demonstrated that plaque from beta carotene-treated patients had higher carotenoid levels and higher absorption (450-500 nm) compared with control specimens, but normal media was unaffected. This demonstration of increased preferential absorption by plaque suggests that selective ablation of atherosclerotic plaque may be enhanced by pretreating patients with oral beta carotene.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom